Recently presented findings in AD have clinical implications now and in the long-term.
By Ronald Devere, MD
Specialists share insights on diagnostic tools, prospects for neuroprotective therapies, and the risk of MS.
By Paul Winnington, Editorial Director
Aspirin resistance is a controversial issue with important clinical implications for neurologists and patients.
By James C. Grotta, MD
As the details of healthcare reform take shape, an ASP may provide a cost-efficient way for clinicians to go digital.
By Mark Kaufmann, MD
A mixture of multiple pathologies may contribute to dementia in most elderly beyond the age of 80.
By Majid Fotuhi, MD, PhD
A simple test can easily determine the presence of small fiber neuropathy. Here’s what you need to know.
By David S. Saperstein, MD and Todd D. Levine, MD
Pseudotumor cerebri occurs in about one in 1,000 people, and a “cause” is often difficult to identify.